Listen & Subscribe

Get The Latest FutureTech Podcast News Delivered Right To Your Inbox

Approximately 15,000 new genomic profiles are analyzed on the SOPHiA GENETICS platform every month, and nearly 1,000 institutions are sharing and comparing this information for the ultimate goal of better understanding the relationship between genes and cancer and rare disorders, coming up with prognostic information, and identifying the best treatments in light of a patient’s genetic profile. General manager of North American operations and VP of business development at SOPHiA GENETICS, Kevin Puylaert, offers a glimpse into a world where massive amounts of data are being collected and analyzed on a regular basis for the betterment of data-driven medicine. He also discusses the details of the work they’re doing and what’s on the horizon in the coming months and years.

Press play for all the details and check out to learn more.

Accessibility Close Menu
Accessibility menu Accessibility menu Accessibility menu
× Accessibility Menu CTRL+U